Ultrasound-Guided Transrectal Implantation of Gold Markers for Prostate Localization During External Beam Radiotherapy: Complication Rate and Risk Factors

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 3, 2007, Pages 671-676

  Langenhuijsen, Johan F ^a   van Lin, Emile N J T ^a   Kiemeney, Lambertus A ^a   van der Vight, Lisette P ^a   McColl, Gill M ^a   Visser, Andries G ^a   Witjes, J Alfred ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Complications; Fiducial gold markers; Prostate cancer; Risk factors; Transrectal implantation

Indexed keywords

BIOMARKERS; HEALTH RISKS; IMPLANTS (SURGICAL); ONCOLOGY; RADIOTHERAPY; TOXICITY;

FIDUCIAL GOLD MARKERS; PROSTATE CANCER; RISK FACTORS; TRANSRECTAL IMPLANTATION;

GOLD;

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CIPROFLOXACIN; GOLD; PREDNISONE;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DRUG ERUPTION; DRUG WITHDRAWAL; EXTERNAL BEAM RADIOTHERAPY; FEVER; HEMATURIA; HEMOSPERMIA; HORMONAL THERAPY; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MICTURITION DISORDER; OUTPATIENT; PAIN; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; RECTUM HEMORRHAGE; RISK FACTOR; TOXICITY; TRANSRECTAL ULTRASONOGRAPHY; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; GASTROINTESTINAL HEMORRHAGE; GOLD; HEMATURIA; HEMOSPERMIA; HUMANS; MALE; MIDDLE AGED; PAIN; PROSTATE; PROSTATIC NEOPLASMS; PROSTHESES AND IMPLANTS; QUESTIONNAIRES; RECTAL DISEASES; RISK FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 34548661501     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.04.009     Document Type: Article

References (29)

1. Peeters S.T., Heemsbergen W.D., Koper P.C., et al. Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24 (2006) 1990-1996
2. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 294 (2005) 1233-1239
3. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
4. Langen K.M., and Jones D.T. Organ motion and its management. Int J Radiat Oncol Biol Phys 50 (2001) 265-278
5. Balter J.M., Sandler H.M., Lam K., et al. Measurement of prostate movement over the course of routine radiotherapy using implanted markers. Int J Radiat Oncol Biol Phys 31 (1995) 113-118
6. Vigneault E., Pouliot J., Laverdiere J., et al. Electronic portal imaging device detection of radiopaque markers for the evaluation of prostate position during megavoltage irradiation: A clinical study. Int J Radiat Oncol Biol Phys 37 (1997) 205-212
7. Dehnad H., Nederveen A.J., van der Heide U.A., et al. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother Oncol 67 (2003) 295-302
8. Litzenberg D., Dawson L.A., Sandler H., et al. Daily prostate targeting using implanted radiopaque markers. Int J Radiat Oncol Biol Phys 52 (2002) 699-703
9. Wu J., Haycocks T., Alasti H., et al. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocenter set-up verification and implanted prostate markers. Radiother Oncol 61 (2001) 127-133
10. Schallenkamp J.M., Herman M.G., Kruse J.J., et al. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int J Radiat Oncol Biol Phys 63 (2005) 800-811
11. Van Lin E.N., van der Vight L.P., Witjes J.A., et al. The effect of an endorectal balloon and off-line correction on the interfraction systematic and random prostate position variations: A comparative study. Int J Radiat Oncol Biol Phys 61 (2005) 278-288
12. Van den Heuvel F., Fugazzi J., Seppi E., et al. Clinical application of a repositioning scheme, using gold markers and portal imaging. Radiother Oncol 79 (2006) 94-100
13. Pouliot J., Aubin M., Langen K.M., et al. (Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device. Int J Radiat Oncol Biol Phys 56 (2003) 862-866
14. Henry A.M., Wilkinson C., Wylie J.P., et al. Trans-perineal implantation of radio-opaque treatment verification markers into the prostate: An assessment of procedure related morbidity, patient acceptability and accuracy. Radiother Oncol 73 (2004) 57-59
15. Norberg M., Holmberg L., Häggman M., et al. Determinants of complications after multiple transrectal core biopsies of the prostate. Eur Radiol 6 (1996) 457-461
16. Rodriguez L.V., and Terris M.K. Risks and complications of transrectal ultrasound guided prostate needle biopsy: A prospective study and review of the literature. J Urol 160 (1998) 2115-2120
17. Gustafsson O., Norming U., Nyman C.R., et al. Complications following combined transrectal aspiration and core biopsy of the prostate. Scand J Urol Nephrol 24 (1990) 249-251
18. Djavan B., Waldert M., Zlotta A., et al. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: Results of a prospective European prostate cancer detection study. J Urol 166 (2001) 856-860
19. Aus G., Hermansson C.G., Hugosson J., et al. Transrectal ultrasound examination of the prostate: Complications and acceptance by patients. Br J Urol 71 (1993) 457-459
20. Rietbergen J.B., Kruger A.E., Kranse R., et al. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: Evaluation of complication rates and risk factors within a population-based screening program. Urology 49 (1997) 875-880
21. Raaijmakers R., Kirkels W.J., Roobol M.J., et al. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 60 (2002) 826-830
22. Clements R., Aideyan O.U., Griffiths G.J., et al. Side effects and patient acceptability of transrectal biopsy of the prostate. Clin Radiol 47 (1993) 125-126
23. Collins G.N., Lloyd S.N., Hehir M., et al. Multiple transrectal ultrasound-guided prostatic biopsies-true morbidity and patient acceptance. Br J Urol 71 (1993) 460-463
24. Irani J., Fournier F., Bon D., et al. Patient tolerance of transrectal ultrasound-guided biopsy of the prostate. Br J Urol 79 (1997) 608-610
25. Colombel M., Filleur S., Fournier P., et al. Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate. Cancer Res 65 (2005) 300-308
26. Pili R., Guo Y., Chang J., et al. Altered angiogenesis underlying age-dependent changes in tumor growth. J Natl Cancer Inst 86 (1994) 1303-1314
27. Scrabrough T.J., Golden N.M., Ting J.Y., et al. Comparison of ultrasound and implanted seed marker prostate localization methods: Implication of image-guided radiotherapy. Int J Radiat Oncol Biol Phys 65 (2006) 378-387
28. Willoughby T.R., Kupelian P.A., Pouliot J., et al. Target localization and real-time tracking using the Calypso 4D localized prostate cancer. Int J Radiat Oncol Biol Phys 65 (2006) 528-534
29. Huisman H.J., Fütterer J.J., van Lin E.N., et al. Prostate cancer: Precision of integrating functional MR imaging with radiation therapy treatment by using gold markers. Radiology 236 (2005) 311-317